Press Releases :: Lexaria Bioscience Corp. (LEXX)

Jul 14, 2022 9:10am EDT

Lexaria To Receive Third Patent Granted in Japan; Submits FDA Filing

Jul 13, 2022 9:05am EDT

Lexaria's Human Nicotine Study Nearing Start Date

Jul 07, 2022 9:05am EDT

Cannadips is Expanding Internationally, Leveraging Lexaria's DehydraTECH

Jun 21, 2022 9:00am EDT

Lexaria Signs Manufacturing and License Agreements with BevNology

Jun 08, 2022 9:00am EDT

Lexaria Grants License to AnodGen Bioceuticals

Jun 06, 2022 9:15am EDT

Lexaria Files Pre-IND Meeting Request Letter with U.S. FDA

Jun 03, 2022 2:00am EDT

Lexaria Grants Exclusive License to Premier Wellness Science Co., Ltd. for Strategic and Long-Term Partnership in the Japanese Market

Jun 02, 2022 9:05am EDT

Lexaria Grants License to Valcon Medical for the European Market

Jun 01, 2022 9:00am EDT

Lexaria Announces 2022 Annual Meeting Results

May 26, 2022 8:30am EDT

Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space

rss_feed News RSS